1[1]Soper JT,Mntch DG,Schink JC,et al.Diagnosis and treatment of gestational trophoblastic disease.ACOG Practic Bulletin No.53[J].Obstet Gynecol,2004,103:1365-137. 被引量：1
2[2]Ngan HY.The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia[J].Int J Gynecol Cancer,2004,14:202-205. 被引量：1
3[3]Hancock BW,Welch EM,Gillospie AM,et al.A retrospective comparison of current and proposed staging and scoring systems for persistent trophoblastic disease[J].Int J Gynecol Cancer,2000,10:318-322. 被引量：1
4[4]Kohorn EI.Dynamic staging and risk factor scoring for gestational trophoblastic disease[J].Int J Gynecol Cancer,2007,17:1124-1130. 被引量：1
5[5]Gillespie AM,Kumar S,Hancock BW.Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy[J].Br J Cancer,2000,82(8):1393-1395. 被引量：1
6[6]Pezeshki M,Hancoci BW,Silcocks P,et al.The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease[J].Gynecol Oncol,2004,95 (3):423-429. 被引量：1
7[7]Goldstein DP,Garner EI,Feltmate CM,et al.The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease[J].Gynecol Oneol,2004,95 (3):423-429. 被引量：1
8[8]van Trommel NE,Massuger LF,Verheijen RH,et al.The curative effect of a second curettage in persistent trophoblastic disease:a rethospective cohort survey[J].Gynecol Oncol,2005,99(1):6-13. 被引量：1
9[9]Elizabeth I.O.Garner,Colleen MF,Donald P,et al.The curative effect of a second curettage in persistent trophoblastic disease:A retrospective cohort survey[J].Gynecol Oncol,2005,99:3-5. 被引量：1
10[10]Abrao RA,de Andrade JM,Tiezzi DG,et al.Treatment for low-risk gestational trophoblastic disease:Comparison of single-agent methotrxate,dactinomycin and combination regimens[J].Gynecol Oncol,2008,108(1):149-153. 被引量：1
二级参考文献11
1Soper JT, Clarke-Person DL, Berchuck A, et al. 5-day methotrexate for woman with metastatic gestational trophoblastic disease. Gynecol Oncol, 1994,54:76-79. 被引量：1
2Hancock BW,Newlands ES, Berkowitz RS. Gestational trophoblastic disease. New York:Chaman & Hall Medical,1997. 被引量：1
3The FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia. Int J Gynecol Obstet,2002,77:285-287. 被引量：1
4Benedet JL, Bender H, Jones H 3rd, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet, 2000,70:209 -262. 被引量：1
8Garret AP, Garner EO,Goldstein DP,et al. Methotrexate and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumor. J Reprod Med ,2002,47:355-362. 被引量：1
9McNeish IA , Strickland S, Holden L, et al. Low-Risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol,2000,20 : 1838-1844. 被引量：1
10Nevin J, Silcocks P, Hancock B, et al. Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor. Gynecol Oncol,2000,78:92-96. 被引量：1
2FIGO Oncology Committee.??FIGO staging for gestational trophoblastic neoplasia 2000(J)International Journal of Gynecology and Obstetrics . 2002 (3) 被引量：2
3Frank D Cirisano,John T Soper.??Practical management of gestational trophoblastic disease(J)Primary Care Update for Ob/Gyns . 1999 (3) 被引量：1
4Fong Pui-Yee,Xue Wei-Cheng,Ngan Hextan Y S,Chan Kelvin Y K,Khoo Ui-Soon,Tsao Siu-Wah,Chiu Pui-Man,Man Lai-Shan,Cheung Annie N Y.Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study. Cancer . 2004 被引量：1
5Xingsheng Yang,Zhenguo Zhang,Chongqi Jia,Jiafu Li,Lijj Yin,Sen Jiang.??The Relationship Between Expression of c-ras, c-erbB-2, nm23, and p53 Gene Products and Development of Trophoblastic Tumor and Their Predictive Significance for the Malignant Transformation of Complete Hydatidiform Mole(J)Gynecologic Oncology . 2002 (3) 被引量：1
